Global Asthma Market 2014-2018 |
Posted: October 9, 2014 |
Asthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a chronic ailment of the respiratory tract, which is caused by the obstruction of the flow of air and bronchospasms, where the muscles around the respiratory tract swell up. The disease is believed to be caused by genetic as well as environmental factors. The American Academy of Allergy Asthma and Immunology classifies asthma under four categories: exercise-induced asthma, allergic asthma, occupational asthma, and childhood asthma. The Asthma and Allergy Foundation of America classifies asthma into two categories: allergic asthma and non-allergic asthma. It is an incurable disease but can be controlled with the help of diagnosis at the right time, followed by regular therapy. TechNavio's analysts forecast the Global Asthma Market to grow at a CAGR of 4.50 percent over the period 2013-2018.
Covered in this Report This report covers the present scenario and the growth prospects of the Global Asthma market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various class of drugs used in the treatment of asthma: Bronchodilators Leukotriene antagonists Mast cell stabilizers Immunosuppressants
TechNavio's report, the Global Asthma Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Asthma Market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. Key Regions Americas, APAC,EMEA,Key Vendors,AstraZeneca,F. Hoffmann-La Roche,GlaxoSmithKline,Merck,Novartis
Other Prominent Vendors
Abbott, Actavis, Amgen, AptarGroup, Astellas, Aurobindo, Biotest, Boehringer Ingelheim, Chiesi Farmaceutici, Cipla, Cytos, Dainippon Sumitomo, Dr. Reddy's Laboratories, Glenmark, Medicinova, Mylan, Ono Pharmaceutical, Orchid Chemicals and Pharmaceuticals, Perrigo, Pfizer, Ranbaxy, Rottapharm Madaus, Skyepharma, Sosei, Sunovion, Teva, Theravance, Vectura
Market Driver Rise in Prevalence of Disease For a full, detailed list, view our report
Market Challenge Unknown Etiology of Disease For a full, detailed list, view our report
Market Trend Popularity of Combination Therapies
Key Questions Answered in this Report What will the market size be in 2018 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors?
For further insights, Get Sample here: - http://www.researchonglobalmarkets.com/pubmod/index/getsample/id/81684
About Research on Global Markets Research on Global Markets is a leading source for market research on various sectors globally, offering premium research content from worldwide publishers of market research reports. Our database hosts premium market research content developed by global publishers. It offers premium industry research reports, company profiles and country briefs. We have a dedicated team of research professionals who can facilitate, in an unbiased manner, the process of identifying appropriate market research reports that are targeted to fulfill all your information-related requirements.
For more details on the content of each report and ordering information please contact: Phone: US/CAN: +1 800 986 6819 UK: +44 203 514 2363 India: +91 22 4098 7600 E-Mail: [email protected] Source: Researchonglobalmarkets.com
|
||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
